Secondary structure in the H19 transcript, which is altered through a SNP in DCM patients, is an attractive target for future studies investigating the molecular mechanism by which H19 contributes to
Here we present dimethyl sulfate mutational profiling with sequencing (DMS-MaPseq), which encodes DMS modifications as mismatches using a thermostable group II intron reverse transcriptase (TGIRT)